Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H15N2O2.Cl |
Molecular Weight | 182.6487 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[N+](C)(C)CCOC(=N)[O-].Cl
InChI
InChIKey=AIXAANGOTKPUOY-UHFFFAOYSA-N
InChI=1S/C6H14N2O2.ClH/c1-8(2,3)4-5-10-6(7)9;/h4-5H2,1-3H3,(H-,7,9);1H
Molecular Formula | C6H15N2O2 |
Molecular Weight | 147.1957 |
Charge | 1 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | ClH |
Molecular Weight | 36.4609 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL220 |
6.0 mM [Kd] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | MIOSTAT Approved UseIntraocular use for obtaining miosis during surgery. In addition, MIOSTAT (carbachol intraocular solution, USP) reduces the intensity of intraocular pressure elevation in the first 24 hours after cataract surgery. Launch Date8.6486401E10 |
PubMed
Title | Date | PubMed |
---|---|---|
Sustained atrial fibrillation induced by carbachol, methacholine and bethanechol. | 1971 Apr |
|
Motor disturbances produced by intrastriatal injection of cyclic AMP and cyclic GMP. | 1976 Nov |
|
Midbrain interaction with the hypothalamus in expression of aggressive behavior in cats. | 1977 |
|
Muscarine- and carbachol-induced aggressions: fear and irritable kinds of aggressions. | 1977 Dec 28 |
|
Evidence that a nigral gabaergic--cholinergic balance controls posture. | 1979 Jan 1 |
|
[Effects of atropine and scopolamine on the aggressive behavior and convulsions induced by carbachol and eserine injected into the cerebral ventricles of the cat]. | 1980 |
|
Seizures induced by carbachol, morphine, and leucine-enkephalin: a comparison. | 1983 Apr |
|
Neuropharmacology of the parasitic trematode, Schistosoma mansoni. | 1983 Jan |
|
Drug-induced modulation of locomotor hyperactivity induced by picrotoxin in nucleus accumbens. | 1984 Oct |
|
Subclassification of muscarinic receptors in the heart, urinary bladder and sympathetic ganglia in the pithed rat. Selectivity of some classical agonists. | 1985 Dec |
|
A crucial epileptogenic site in the deep prepiriform cortex. | 1985 Oct 17-23 |
|
Cholinergic induction of seizures in the rat prefrontal cortex. | 1986 Jun 23 |
|
Neuropeptide Y and calcitonin gene-related peptide: effects on glucagon and insulin secretion in the mouse. | 1987 |
|
Cardiovascular effects of cholinergic agents in the ventral-lateral midbrain periaqueductal gray of the rat. | 1987 Dec |
|
Novel 'soft' anticholinergic agents. | 1988 Feb |
|
The effect of cholinergic stimulation in the nucleus accumbens on locomotor behavior. | 1988 Feb 16 |
|
Anatomical analysis of frontal cortex sites at which carbachol induces motor seizures in the rat. | 1988 May |
|
Renal function during onset of carbachol-induced hypertension in conscious rats. | 1990 |
|
Catalepsy induced by carbachol microinjected into the pontine reticular formation of rats. | 1990 Jul 31 |
|
Excitatory modulation by a spinal cholinergic system of a descending sympathoexcitatory pathway in rats. | 1992 Mar |
|
Sites at which neuropeptide Y modulates parasympathetic control of heart rate in guinea pigs and rats. | 1992 May 1 |
|
Regeneration of cardiomyocytes from bone marrow: Use of mesenchymal stem cell for cardiovascular tissue engineering. | 2003 Mar |
|
Pharmacokinetic and pharmacodynamic evaluations of the zwitterionic metabolite of a new series of N-substituted soft anticholinergics. | 2005 Dec |
|
Actin and non-muscle myosin II facilitate apical exocytosis of tear proteins in rabbit lacrimal acinar epithelial cells. | 2005 Oct 15 |
|
Theoretical and experimental investigation of calcium-contraction coupling in airway smooth muscle. | 2006 |
|
Case report: acute unintentional carbachol intoxication. | 2006 |
|
Muscarinic acetylcholine receptors mediate oligodendrocyte progenitor survival through Src-like tyrosine kinases and PI3K/Akt pathways. | 2006 Apr |
|
Roles of protein kinase C, Ca2+, Pyk2, and c-Src in agonist activation of rat lacrimal gland p42/p44 MAPK. | 2006 Aug |
|
Novelty exploration elicits a reversal of acute stress-induced modulation of hippocampal synaptic plasticity in the rat. | 2006 Dec 1 |
|
Muscarinic cholinoceptor activation modulates DNA synthesis and CD40 expression in fibroblast cells. | 2006 Jul |
|
[Effects of carbachol on apoptosis of intestinal epithelial cells after gut ischemia/reperfusion in rat]. | 2007 Aug |
|
Gene transfer of neuronal nitric oxide synthase into intracardiac Ganglia reverses vagal impairment in hypertensive rats. | 2007 Feb |
|
Testosterone and progesterone rapidly attenuate plasma membrane Gbetagamma-mediated signaling in Xenopus laevis oocytes by signaling through classical steroid receptors. | 2007 Jan |
|
Endogenous RGS proteins modulate SA and AV nodal functions in isolated heart: implications for sick sinus syndrome and AV block. | 2007 May |
|
Myosin light chain kinase-independent inhibition by ML-9 of murine TRPC6 channels expressed in HEK293 cells. | 2007 Sep |
|
A novel assay of Gi/o-linked G protein-coupled receptor coupling to potassium channels provides new insights into the pharmacology of the group III metabotropic glutamate receptors. | 2008 Apr |
|
Metabotropic receptor-activated calcium increases and store-operated calcium influx in mouse Müller cells. | 2008 Jul |
|
Monitoring the reaction of carbachol with acetylcholinesterase by thioflavin T fluorescence and acetylthiocholine hydrolysis. | 2008 Sep 25 |
|
Histamine H1 receptor induces cytosolic calcium increase and aquaporin translocation in human salivary gland cells. | 2009 Aug |
|
Prediction of functionally selective allosteric interactions at an M3 muscarinic acetylcholine receptor mutant using Saccharomyces cerevisiae. | 2010 Aug |
|
Aggravation of seizure-associated microvascular injuries by ibuprofen may involve multiple pathways. | 2010 Dec |
|
Structural and functional effects of developmental exposure to ethanol on the zebrafish heart. | 2010 Jun |
|
The validation of an in vitro colonic motility assay as a biomarker for gastrointestinal adverse drug reactions. | 2010 Jun 15 |
|
Carbachol induces headache, but not migraine-like attacks, in patients with migraine without aura. | 2010 Mar |
|
Zinc oxide nanoparticle disruption of store-operated calcium entry in a muscarinic receptor signaling pathway. | 2010 Oct |
|
Molecular basis of inhibition of substrate hydrolysis by a ligand bound to the peripheral site of acetylcholinesterase. | 2010 Sep 6 |
|
Antispasmodic effects of eugenol on rat airway smooth muscle. | 2011 Dec |
|
TRPC5 channel sensitivities to antioxidants and hydroxylated stilbenes. | 2011 Feb 18 |
|
Interaction of bispyridinium compounds with the orthosteric binding site of human α7 and Torpedo californica nicotinic acetylcholine receptors (nAChRs). | 2011 Sep 25 |
|
Characterisation of acetylcholinesterase release from neuronal cells. | 2013 Mar 25 |
Patents
Sample Use Guides
MIOSTAT (CARBACHOL INTRAOCULAR SOLUTION, USP) 0.01%
Aseptically remove the sterile vial from the blister package by peeling the backing paper and dropping the vial onto a sterile tray. Withdraw the contents into a dry sterile syringe, and replace the needle with an atraumatic cannula prior to intraocular instillation. No more than one-half milliliter should be gently instilled into the anterior chamber for the production of satisfactory miosis. It may be instilled before or after securing sutures. Miosis is usually maximal within two to five minutes after application.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27118568
In the dose-course studies, carbachol showed significant increase in phosphorylation of MYPT1 at Thr696 (p-MYPT1) from concentrations of 15-100 μM based on Western blot results (p < 0.05, ANOVA test). In the time-course studies, treatment of cells with 15 μM of carbachol significantly enhanced the expression of p-MYPT1 from 3 to 15 h (p < 0.05, ANOVA test) and induced the expression of Rho A from 10 to 120 min (p < 0.05, ANOVA test).
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Jun 25 20:52:11 UTC 2021
by
admin
on
Fri Jun 25 20:52:11 UTC 2021
|
Record UNII |
8Y164V895Y
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29705
Created by
admin on Fri Jun 25 20:52:11 UTC 2021 , Edited by admin on Fri Jun 25 20:52:11 UTC 2021
|
||
|
WHO-ATC |
S01EB02
Created by
admin on Fri Jun 25 20:52:11 UTC 2021 , Edited by admin on Fri Jun 25 20:52:11 UTC 2021
|
||
|
WHO-ATC |
N07AB01
Created by
admin on Fri Jun 25 20:52:11 UTC 2021 , Edited by admin on Fri Jun 25 20:52:11 UTC 2021
|
||
|
NDF-RT |
N0000175884
Created by
admin on Fri Jun 25 20:52:11 UTC 2021 , Edited by admin on Fri Jun 25 20:52:11 UTC 2021
|
||
|
WHO-VATC |
QS01EB02
Created by
admin on Fri Jun 25 20:52:11 UTC 2021 , Edited by admin on Fri Jun 25 20:52:11 UTC 2021
|
||
|
WHO-VATC |
QA03AB92
Created by
admin on Fri Jun 25 20:52:11 UTC 2021 , Edited by admin on Fri Jun 25 20:52:11 UTC 2021
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5831
Created by
admin on Fri Jun 25 20:52:11 UTC 2021 , Edited by admin on Fri Jun 25 20:52:11 UTC 2021
|
PRIMARY | |||
|
C47430
Created by
admin on Fri Jun 25 20:52:11 UTC 2021 , Edited by admin on Fri Jun 25 20:52:11 UTC 2021
|
PRIMARY | |||
|
DB00411
Created by
admin on Fri Jun 25 20:52:11 UTC 2021 , Edited by admin on Fri Jun 25 20:52:11 UTC 2021
|
PRIMARY | |||
|
488
Created by
admin on Fri Jun 25 20:52:11 UTC 2021 , Edited by admin on Fri Jun 25 20:52:11 UTC 2021
|
PRIMARY | |||
|
SUB06087MIG
Created by
admin on Fri Jun 25 20:52:11 UTC 2021 , Edited by admin on Fri Jun 25 20:52:11 UTC 2021
|
PRIMARY | |||
|
298
Created by
admin on Fri Jun 25 20:52:11 UTC 2021 , Edited by admin on Fri Jun 25 20:52:11 UTC 2021
|
PRIMARY | |||
|
1092009
Created by
admin on Fri Jun 25 20:52:11 UTC 2021 , Edited by admin on Fri Jun 25 20:52:11 UTC 2021
|
PRIMARY | USP-RS | ||
|
M3051
Created by
admin on Fri Jun 25 20:52:11 UTC 2021 , Edited by admin on Fri Jun 25 20:52:11 UTC 2021
|
PRIMARY | Merck Index | ||
|
D002217
Created by
admin on Fri Jun 25 20:52:11 UTC 2021 , Edited by admin on Fri Jun 25 20:52:11 UTC 2021
|
PRIMARY | |||
|
CHEMBL965
Created by
admin on Fri Jun 25 20:52:11 UTC 2021 , Edited by admin on Fri Jun 25 20:52:11 UTC 2021
|
PRIMARY | |||
|
51-83-2
Created by
admin on Fri Jun 25 20:52:11 UTC 2021 , Edited by admin on Fri Jun 25 20:52:11 UTC 2021
|
PRIMARY | |||
|
51-83-2
Created by
admin on Fri Jun 25 20:52:11 UTC 2021 , Edited by admin on Fri Jun 25 20:52:11 UTC 2021
|
PRIMARY | |||
|
6373
Created by
admin on Fri Jun 25 20:52:11 UTC 2021 , Edited by admin on Fri Jun 25 20:52:11 UTC 2021
|
PRIMARY | |||
|
1999
Created by
admin on Fri Jun 25 20:52:11 UTC 2021 , Edited by admin on Fri Jun 25 20:52:11 UTC 2021
|
PRIMARY | RxNorm | ||
|
383
Created by
admin on Fri Jun 25 20:52:11 UTC 2021 , Edited by admin on Fri Jun 25 20:52:11 UTC 2021
|
PRIMARY | |||
|
8Y164V895Y
Created by
admin on Fri Jun 25 20:52:11 UTC 2021 , Edited by admin on Fri Jun 25 20:52:11 UTC 2021
|
PRIMARY | |||
|
Carbachol
Created by
admin on Fri Jun 25 20:52:11 UTC 2021 , Edited by admin on Fri Jun 25 20:52:11 UTC 2021
|
PRIMARY | |||
|
200-127-3
Created by
admin on Fri Jun 25 20:52:11 UTC 2021 , Edited by admin on Fri Jun 25 20:52:11 UTC 2021
|
PRIMARY | |||
|
Carbachol
Created by
admin on Fri Jun 25 20:52:11 UTC 2021 , Edited by admin on Fri Jun 25 20:52:11 UTC 2021
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
TARGET -> AGONIST | |||
|
TARGET -> AGONIST | |||
|
TARGET -> AGONIST |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Duration of Action | PHARMACOKINETIC |
|
INTRAOCULAR ADMINISTRATION PHARMACOKINETIC |
|
||